{"id":15636,"date":"2023-02-24T17:36:56","date_gmt":"2023-02-24T17:36:56","guid":{"rendered":"https:\/\/oxfordcorp.com\/?p=15636"},"modified":"2025-06-10T20:47:58","modified_gmt":"2025-06-10T20:47:58","slug":"oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp","status":"publish","type":"post","link":"https:\/\/www.oxfordcorp.com\/de\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/","title":{"rendered":"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp"},"content":{"rendered":"
INDUSTRY<\/strong>
\nLife Sciences<\/p>\n

SERVICES<\/strong>
\nTalent Management Solutions
\nRegulatory and Compliance
\nWorkforce Management<\/p>\n

SKILLS<\/strong>
\nRegulatory and Compliance
\nVerification\/Validation
\nProcess Engineering
\nProject Management
\nAutomation Engineering<\/p>\n<\/div>\n

The Challenge<\/strong><\/p>\n

A global leader in research-based biopharmaceuticals needed automation and verification engineering services to support a large initiative to double the production capacity of the COVID-19 vaccine. The project, which would typically span three to five years, needed to be completed within one year.<\/p>\n

The client was under extreme pressure to carry out the overwhelming request due to a compelling push from the government to address the devastating global situation due to the virus. Additionally, the company\u2019s CEO announced its commitment to double production within the next year to meet the much-needed demand.<\/p>\n

The Solution<\/strong><\/p>\n

The corporation selected Oxford due to past performance in similar areas. Nobody had experience with the vaccine, as the virus was new, and up to this point, an mRNA vaccine had not been commercially developed in regions such as the United States. However, we had previously proven ourselves in onboarding resources, project oversight, and validation. Therefore, the client trusted us to provide quality resources quickly.<\/p>\n

Oxford committed to working through the holidays, providing seven team leads that covered shifts 24\/7. In all, we supplied our client with nearly 50 high-quality automation, verification, and process engineers. They performed troubleshooting and verification testing of a new automated filling line to successfully startup and double production capacity.<\/p>\n

The Result<\/strong><\/p>\n

Oxford played a pivotal role in accelerating the corporation\u2019s vaccine production capabilities. Through strategic collaboration, agile problem-solving, and the deployment of specialized expertise, Oxford enabled the client to meet its ambitious goal of delivering effective vaccine solutions within the calendar year. This achievement not only upheld the corporation\u2019s public commitment but also contributed significantly to global health efforts during a critical period.<\/p>\n","protected":false},"excerpt":{"rendered":"

Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering. <\/p>\n","protected":false},"author":10,"featured_media":22308,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[181],"tags":[113],"category-tag":[],"class_list":["post-15636","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-study","tag-life-sciences"],"yoast_head":"\nOxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp - Oxford Global Resources<\/title>\n<meta name=\"description\" content=\"Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp\" \/>\n<meta property=\"og:description\" content=\"Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxford Global Resources\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-24T17:36:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-10T20:47:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2023\/02\/Website-Graphics-1920-X-1080-23.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Luke Summers\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luke Summers\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/\"},\"author\":{\"name\":\"Luke Summers\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#\\\/schema\\\/person\\\/e880f6edc6bcf421204f294431943cd3\"},\"headline\":\"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp\",\"datePublished\":\"2023-02-24T17:36:56+00:00\",\"dateModified\":\"2025-06-10T20:47:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/\"},\"wordCount\":307,\"image\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Website-Graphics-1920-X-1080-23.jpg\",\"keywords\":[\"Life Sciences\"],\"articleSection\":[\"Case Study\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/\",\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/\",\"name\":\"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp - Oxford Global Resources\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Website-Graphics-1920-X-1080-23.jpg\",\"datePublished\":\"2023-02-24T17:36:56+00:00\",\"dateModified\":\"2025-06-10T20:47:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#\\\/schema\\\/person\\\/e880f6edc6bcf421204f294431943cd3\"},\"description\":\"Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Website-Graphics-1920-X-1080-23.jpg\",\"contentUrl\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Website-Graphics-1920-X-1080-23.jpg\",\"width\":1600,\"height\":900,\"caption\":\"Website Graphics 1920 X 1080 23\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/final-homepage-2\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/\",\"name\":\"Oxford Global Resources\",\"description\":\"Global\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#\\\/schema\\\/person\\\/e880f6edc6bcf421204f294431943cd3\",\"name\":\"Luke Summers\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g\",\"caption\":\"Luke Summers\"},\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/insights\\\/author\\\/lsummersthiel-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp - Oxford Global Resources","description":"Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/","og_locale":"de_DE","og_type":"article","og_title":"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp","og_description":"Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering.","og_url":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/","og_site_name":"Oxford Global Resources","article_published_time":"2023-02-24T17:36:56+00:00","article_modified_time":"2025-06-10T20:47:58+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2023\/02\/Website-Graphics-1920-X-1080-23.png","type":"image\/png"}],"author":"Luke Summers","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Luke Summers","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#article","isPartOf":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/"},"author":{"name":"Luke Summers","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/e880f6edc6bcf421204f294431943cd3"},"headline":"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp","datePublished":"2023-02-24T17:36:56+00:00","dateModified":"2025-06-10T20:47:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/"},"wordCount":307,"image":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2023\/02\/Website-Graphics-1920-X-1080-23.jpg","keywords":["Life Sciences"],"articleSection":["Case Study"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/","url":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/","name":"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp - Oxford Global Resources","isPartOf":{"@id":"https:\/\/www.oxfordcorp.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#primaryimage"},"image":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2023\/02\/Website-Graphics-1920-X-1080-23.jpg","datePublished":"2023-02-24T17:36:56+00:00","dateModified":"2025-06-10T20:47:58+00:00","author":{"@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/e880f6edc6bcf421204f294431943cd3"},"description":"Unique and dire circumstances called for sped-up vaccine production by experts skilled in automation and verification engineering.","breadcrumb":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#primaryimage","url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2023\/02\/Website-Graphics-1920-X-1080-23.jpg","contentUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2023\/02\/Website-Graphics-1920-X-1080-23.jpg","width":1600,"height":900,"caption":"Website Graphics 1920 X 1080 23"},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/oxford-supplies-covid-19-vaccine-assistance-to-biopharma-corp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oxfordcorp.com\/de\/final-homepage-2\/"},{"@type":"ListItem","position":2,"name":"Oxford Supplies COVID-19 Vaccine Assistance to Biopharma Corp"}]},{"@type":"WebSite","@id":"https:\/\/www.oxfordcorp.com\/de\/#website","url":"https:\/\/www.oxfordcorp.com\/de\/","name":"Oxford Global Resources","description":"Global","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxfordcorp.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/e880f6edc6bcf421204f294431943cd3","name":"Luke Summers","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g","caption":"Luke Summers"},"url":"https:\/\/www.oxfordcorp.com\/de\/insights\/author\/lsummersthiel-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/posts\/15636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/comments?post=15636"}],"version-history":[{"count":0,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/posts\/15636\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/media\/22308"}],"wp:attachment":[{"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/media?parent=15636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/categories?post=15636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/tags?post=15636"},{"taxonomy":"category-tag","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/de\/wp-json\/wp\/v2\/category-tag?post=15636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}